Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hedley Griffiths

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Case Reports in Rheumatology|March 17, 2016
Atypical Cutaneous Manifestations in Adult Onset Still's DiseaseChampa Nataraja, Hedley Griffiths
Patient Preference and Adherence|July 8, 2021
Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research StudyJuan Aw, Hedley Griffiths, Jane Zochling, et al.
Clinical Rheumatology|August 9, 2021
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in AustraliaPaul Bird, Geoffrey Littlejohn, Belinda Butcher, et al.
The Journal of Rheumatology|August 2, 2021
Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL DatasetHedley Griffiths, Tegan Smith, Christopher Mack, et al.
International Journal of Rheumatology|June 1, 2018
AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid ArthritisPaul Bird, Charles Peterfy, Peter Countryman, et al.
BMC Musculoskeletal Disorders|January 11, 2014
Rheumatoid arthritis and incident fracture in women: a case-control studySharon L Brennan, Liesje Toomey, Mark A Kotowicz, et al.
Clinical Rheumatology|April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
Clinical Rheumatology|March 12, 2020
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in AustraliaPaul Bird, Geoffrey Littlejohn, Belinda Butcher, et al.
Internal Medicine Journal|November 27, 2023
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savingsClaire T Deakin, Geoffrey O Littlejohn, Hedley Griffiths, et al.
Internal Medicine Journal|July 4, 2018
Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REALDave Nicholls, Rina Barrett, Peter Button, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Case Reports in Rheumatology|March 17, 2016
Atypical Cutaneous Manifestations in Adult Onset Still's DiseaseChampa Nataraja, Hedley Griffiths
Patient Preference and Adherence|July 8, 2021
Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research StudyJuan Aw, Hedley Griffiths, Jane Zochling, et al.
Clinical Rheumatology|August 9, 2021
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in AustraliaPaul Bird, Geoffrey Littlejohn, Belinda Butcher, et al.
The Journal of Rheumatology|August 2, 2021
Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL DatasetHedley Griffiths, Tegan Smith, Christopher Mack, et al.
International Journal of Rheumatology|June 1, 2018
AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid ArthritisPaul Bird, Charles Peterfy, Peter Countryman, et al.
BMC Musculoskeletal Disorders|January 11, 2014
Rheumatoid arthritis and incident fracture in women: a case-control studySharon L Brennan, Liesje Toomey, Mark A Kotowicz, et al.
Clinical Rheumatology|April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
Clinical Rheumatology|March 12, 2020
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in AustraliaPaul Bird, Geoffrey Littlejohn, Belinda Butcher, et al.
Internal Medicine Journal|November 27, 2023
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savingsClaire T Deakin, Geoffrey O Littlejohn, Hedley Griffiths, et al.
Internal Medicine Journal|July 4, 2018
Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REALDave Nicholls, Rina Barrett, Peter Button, et al.
Pageof 3